FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034114703> ?p ?o ?g. }

• W2034114703 endingPage "0" @default.
• W2034114703 startingPage "0" @default.
• W2034114703 abstract "Adalimumab in ankylosing spondylitis: an evidence-based review of its place in therapy Stephanie Hennigan, Christoph Ackermann, Arthur KavanaughCenter for Innovative Therapy, Division of Rheumatology, Allergy and Immunology, University of California, La Jolla, California, USAIntroduction: Ankylosing spondylitis (AS) is an idiopathic chronic inflammatory disease that has prominent effects on the spine and peripheral joints. In addition, extraarticular manifestations such as enthesitis and acute anterior uveitis may be clinically important. In recent years, the therapy of AS has changed, largely due to the introduction of inhibitors of the proinflammatory cytokine tumor necrosis factor (TNF). Adalimumab, a human monoclonal antibody specifically for TNF, is the most recent of the TNF blocking agents that have been approved for the treatment of active, nonsteroidal antiinflammatory drug (NSAID)-refractory patients with AS.Aims: To evaluate the evidence for the therapeutic value of adalimumab in ankylosing spondylitis.Evidence review: There is clear evidence that adalimumab, administered 40 mg subcutaneously every 2 weeks, substantially improves the signs and symptoms of NSAID-refractory, active AS when compared with placebo treatment. There is ample evidence that adalimumab causes significant improvements in physical health status and overall AS-specific, health-related quality of life and physical functioning, which consequently leads to better work productivity. There is substantial evidence that adalimumab improves spinal and sacroiliac joint inflammation in AS patients. Initial results from clinical trials suggest that there is no increased risk of serious infections or malignancies in adalimumab-treated patients with AS. The most common adverse events were injection-site reactions. Limited economic evidence suggests that adalimumab 40 mg may be cost effective when used according to current valid treatment guidelines. Place in therapy: Adalimumab is an effective treatment for patients with active AS.Key words: adalimumab, ankylosing spondylitis, TNF inhibitor, evidence, treatment" @default.
• W2034114703 created "2016-06-24" @default.
• W2034114703 creator A5012114873 @default.
• W2034114703 creator A5014045275 @default.
• W2034114703 creator A5031915585 @default.
• W2034114703 date "2007-12-01" @default.
• W2034114703 modified "2023-09-25" @default.
• W2034114703 title "Adalimumab in ankylosing spondylitis: an evidence-based review of its place in therapy" @default.
• W2034114703 cites W1596546277 @default.
• W2034114703 cites W1875343695 @default.
• W2034114703 cites W1882716867 @default.
• W2034114703 cites W1892885058 @default.
• W2034114703 cites W1964651200 @default.
• W2034114703 cites W1967501597 @default.
• W2034114703 cites W1968156222 @default.
• W2034114703 cites W1979060964 @default.
• W2034114703 cites W1987533792 @default.
• W2034114703 cites W1990043465 @default.
• W2034114703 cites W1990305566 @default.
• W2034114703 cites W1995356102 @default.
• W2034114703 cites W2018697945 @default.
• W2034114703 cites W2030187620 @default.
• W2034114703 cites W2034699258 @default.
• W2034114703 cites W2061275436 @default.
• W2034114703 cites W2062092608 @default.
• W2034114703 cites W2066738382 @default.
• W2034114703 cites W2077199006 @default.
• W2034114703 cites W2085267090 @default.
• W2034114703 cites W2088736174 @default.
• W2034114703 cites W2100150957 @default.
• W2034114703 cites W2100675242 @default.
• W2034114703 cites W2102829569 @default.
• W2034114703 cites W2103778140 @default.
• W2034114703 cites W2113411136 @default.
• W2034114703 cites W2118203621 @default.
• W2034114703 cites W2121157358 @default.
• W2034114703 cites W2123166286 @default.
• W2034114703 cites W2125623644 @default.
• W2034114703 cites W2141081169 @default.
• W2034114703 cites W2142080833 @default.
• W2034114703 cites W2148560066 @default.
• W2034114703 cites W2156712409 @default.
• W2034114703 cites W2156996668 @default.
• W2034114703 cites W2158968701 @default.
• W2034114703 cites W2163493960 @default.
• W2034114703 cites W2170050330 @default.
• W2034114703 cites W2170446962 @default.
• W2034114703 cites W2334433685 @default.
• W2034114703 cites W2336936581 @default.
• W2034114703 cites W2398835846 @default.
• W2034114703 cites W2523734900 @default.
• W2034114703 cites W2594764447 @default.
• W2034114703 cites W7644774 @default.
• W2034114703 cites W1585286298 @default.
• W2034114703 cites W179140423 @default.
• W2034114703 doi "https://doi.org/10.2147/ce.s7432" @default.
• W2034114703 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3012440" @default.
• W2034114703 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21221193" @default.
• W2034114703 hasPublicationYear "2007" @default.
• W2034114703 type Work @default.
• W2034114703 sameAs 2034114703 @default.
• W2034114703 citedByCount "2" @default.
• W2034114703 countsByYear W20341147032012 @default.
• W2034114703 countsByYear W20341147032013 @default.
• W2034114703 crossrefType "journal-article" @default.
• W2034114703 hasAuthorship W2034114703A5012114873 @default.
• W2034114703 hasAuthorship W2034114703A5014045275 @default.
• W2034114703 hasAuthorship W2034114703A5031915585 @default.
• W2034114703 hasBestOaLocation W20341147031 @default.
• W2034114703 hasConcept C126322002 @default.
• W2034114703 hasConcept C17991360 @default.
• W2034114703 hasConcept C197934379 @default.
• W2034114703 hasConcept C2777402515 @default.
• W2034114703 hasConcept C2779650986 @default.
• W2034114703 hasConcept C2780132546 @default.
• W2034114703 hasConcept C71924100 @default.
• W2034114703 hasConceptScore W2034114703C126322002 @default.
• W2034114703 hasConceptScore W2034114703C17991360 @default.
• W2034114703 hasConceptScore W2034114703C197934379 @default.
• W2034114703 hasConceptScore W2034114703C2777402515 @default.
• W2034114703 hasConceptScore W2034114703C2779650986 @default.
• W2034114703 hasConceptScore W2034114703C2780132546 @default.
• W2034114703 hasConceptScore W2034114703C71924100 @default.
• W2034114703 hasLocation W20341147031 @default.
• W2034114703 hasLocation W20341147032 @default.
• W2034114703 hasOpenAccess W2034114703 @default.
• W2034114703 hasPrimaryLocation W20341147031 @default.
• W2034114703 hasRelatedWork W1976601340 @default.
• W2034114703 hasRelatedWork W2067316183 @default.
• W2034114703 hasRelatedWork W2076485791 @default.
• W2034114703 hasRelatedWork W2130595966 @default.
• W2034114703 hasRelatedWork W2361702380 @default.
• W2034114703 hasRelatedWork W2462015932 @default.
• W2034114703 hasRelatedWork W2597927063 @default.
• W2034114703 hasRelatedWork W4281286897 @default.
• W2034114703 hasRelatedWork W4281639206 @default.
• W2034114703 hasRelatedWork W4312185468 @default.
• W2034114703 isParatext "false" @default.

• next